# STILDEP: Zolpidem in Depressive and Dysthimic Patients

> **NCT00292734** · PHASE4 · COMPLETED · sponsor: **Sanofi** · enrollment: 120 (—)

## Conditions studied

- Sleep Initiation and Maintenance Disorders
- Depression

## Interventions

- **DRUG:** Zolpidem

## Key facts

- **NCT ID:** NCT00292734
- **Lead sponsor:** Sanofi
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2005-01
- **Primary completion:** —
- **Final completion:** 2006-06
- **Target enrollment:** 120 (—)
- **Last updated:** 2007-12-06


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00292734

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00292734, "STILDEP: Zolpidem in Depressive and Dysthimic Patients". Retrieved via AI Analytics 2026-06-12 from https://api.ai-analytics.org/clinical/NCT00292734. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*